2019
DOI: 10.1080/01913123.2019.1673863
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation and plasticity of human vascular wall mesenchymal stem cells, dermal fibroblasts and myofibroblasts: a critical comparison including ultrastructural evaluation of osteogenic potential

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…hRIFs are one of the main cells in kidney interstitial tissue. Studies have shown that the fibroblasts in multiorganization have osteogenic differentiation potential (34,35). However, there are no reports on the osteogeniclike differentiation of hRIFs.…”
Section: Discussionmentioning
confidence: 99%
“…hRIFs are one of the main cells in kidney interstitial tissue. Studies have shown that the fibroblasts in multiorganization have osteogenic differentiation potential (34,35). However, there are no reports on the osteogeniclike differentiation of hRIFs.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, there are also studies that have provided evidence of greater antiinflammatory and wound-healing features of MSCs in comparison to other stromal cells [25]. In an array of in-vitro tests to compare human artery-wall-derived MSCs with dermal fibroblasts and myofibroblasts, Pasanisi et al showed some profound differences in the immunomodulatory properties between these cell types [25].…”
Section: Common Properties: Tissue Remodeling and Immunomodulationmentioning
confidence: 99%
“…In contrast, there are also studies that have provided evidence of greater antiinflammatory and wound-healing features of MSCs in comparison to other stromal cells [25]. In an array of in-vitro tests to compare human artery-wall-derived MSCs with dermal fibroblasts and myofibroblasts, Pasanisi et al showed some profound differences in the immunomodulatory properties between these cell types [25]. Both the dermal fibroblasts and myofibroblasts expressed very low levels of immunomodulatory and inflammation-related genes, and had lower immunosuppressive potential for proliferation of peripheral blood mononuclear cells in comparison to the femoral artery MSCs.…”
Section: Common Properties: Tissue Remodeling and Immunomodulationmentioning
confidence: 99%
See 2 more Smart Citations